CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

FDA Biologics (BLA & Biosimilars)
Original article

OTP Town Hall: CMC Readiness for Gene Therapy BLAs - 06/04/2024

Neutral
AI Analysis

Summary

The FDA's CBER Office of Therapeutic Products is hosting a virtual town hall on June 4, 2024, to discuss chemistry, manufacturing, and controls (CMC) information requirements for gene therapy biologics license applications.

Importance:2/10
Sentiment:
0.00
Gene TherapyBLACMCFDACBERTown HallRegulatory

Read the original article

Published by FDA Biologics (BLA & Biosimilars) on August 6, 2026 6:35 PM

Read Original